Co-amplified RNAs for Comparitive Microarray Analysis

Information

  • Research Project
  • 6443761
  • ApplicationId
    6443761
  • Core Project Number
    R43CA088693
  • Full Project Number
    1R43CA088693-01A1
  • Serial Number
    88693
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/19/2002 - 22 years ago
  • Project End Date
    1/31/2003 - 21 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    6/19/2002 - 22 years ago
  • Budget End Date
    1/31/2003 - 21 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    6/19/2002 - 22 years ago
Organizations

Co-amplified RNAs for Comparitive Microarray Analysis

Ambion, Inc. proposes to develop methods and reagents that will make it possible to compare the expression profiles of small RNA samples (<1 microgram of RNA) using microarray analysis. The key element of the proposal is an amplification scheme that will allow two RNA populations to be co-verse transcribed and co-amplified in a single tube using the same reagents. Simultaneous amplification will obviate the effects of tube-to-tube variation that plagues current amplification schemes. Following amplification, sequences derived from the two input RNA samples will be labeled with different fluorescent dyes and the two target populations will be hybridized to a single microarray. In addition to a method for RNA amplification, Ambion proposes to improve the sensitivity of microarrays by developing an enhanced microarray hybridization solution by systematically assessing the benefits of known hybridization enhancers. Finally, an RNA reference population will be developed that will provide a standard against which data from many different experiments can be compared. PROPOSED COMMERCIAL APPLICATIONS: The proposed research has many commercial applications. Success in Phase I will result in an enhanced microarray hybridization system and internal control problems that will be useful for all microarray expression research. Phase II success will result in an amplification system that can be applied by individual researchers using limited RNA samples. Ambion will use the amplification scheme to provide nucleic acids from difficult to obtain samples to the research community.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    120930
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:120930\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AMBION, INC.
  • Organization Department
  • Organization DUNS
    198680068
  • Organization City
    AUSTIN
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    787441832
  • Organization District
    UNITED STATES